10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2013 | |||
Consolidated Statements of Earnings | |||
Period Ending Dec 29, 2013 10-K (Filed: Feb 21, 2014) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 | |
| Sales to customers | $ 71,312 | 67,224 | 65,030 |
| Cost of products sold | 22,342 | 21,658 | 20,360 |
| Gross profit | 48,970 | 45,566 | 44,670 |
| Selling, marketing and administrative expenses | 21,830 | 20,869 | 20,969 |
| Research and development expense | 8,183 | 7,665 | 7,548 |
| In-process research and development | 580 | 1,163 | 0 |
| Interest income | (74) | (64) | (91) |
| Interest expense, net of portion capitalized (Note 4) | 482 | 532 | 571 |
| Other (income) expense, net | 2,498 | 1,626 | 2,743 |
| Restructuring (Note 22) | 0 | 0 | 569 |
| Earnings before provision for taxes on income | 15,471 | 13,775 | 12,361 |
| Provision for taxes on income (Note 8) | 1,640 | 3,261 | 2,689 |
| Net earnings | 13,831 | 10,514 | 9,672 |
| Add: Net loss attributable to noncontrolling interest | 0 | 339 | 0 |
| Net earnings attributable to Johnson & Johnson | 13,831 | 10,853 | 9,672 |
| Net earnings per share attributable to Johnson & Johnson (Notes 1 and 15) | |||
| Basic | 4.92 | 3.94 | 3.54 |
| Diluted | 4.81 | 3.86 | 3.49 |
| Cash dividends per share | 2.59 | 2.40 | 2.25 |
| Average shares outstanding (Notes 1 and 15) | |||
| Basic | 2,809,200 | 2,753,300 | 2,736,000 |
| Diluted | 2,877,000 | 2,812,600 | 2,775,300 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2013 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 29, 2013 10-K (Filed: Feb 21, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 | |
| Net Earnings | $ 13,831 | 10,514 | 9,672 |
| Other Comprehensive Income (Loss), net of tax | |||
| Foreign currency translation | 94 | 1,230 | (557) |
| Securities | |||
| Unrealized holding gain (loss) arising during period | 225 | (248) | 565 |
| Reclassifications to earnings | (314) | (5) | (141) |
| Net change | (89) | (253) | 424 |
| Employee benefit plans | |||
| Prior service cost amortization during period | 9 | 2 | 5 |
| Prior service cost - current year | (27) | (8) | 15 |
| Gain amortization during period | 515 | 370 | 246 |
| Gain (loss) - current year | 2,203 | (1,643) | (1,984) |
| Effect of exchange rates | 8 | (52) | 18 |
| Net change | 2,708 | (1,331) | (1,700) |
| Derivatives & hedges | |||
| Unrealized gain (loss) arising during period | 344 | 52 | (500) |
| Reclassifications to earnings | (107) | 124 | 232 |
| Net change | 237 | 176 | (268) |
| Other Comprehensive Income (Loss) | 2,950 | (178) | (2,101) |
| Total comprehensive income | 16,781 | 10,336 | 7,571 |
| Comprehensive Loss Attributable To Noncontrolling Interest, net of tax | 0 | 339 | 0 |
| Comprehensive Income Attributable To Johnson & Johnson | 16,781 | 10,675 | 7,571 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 29, 2013 10-K (Filed: Feb 21, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 | |
| CASH FLOW FROM OPERATING ACTIVITIES | |||
| Net Earnings | $ 13,831 | 10,514 | 9,672 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 4,104 | 3,666 | 3,158 |
| Stock based compensation | 728 | 662 | 621 |
| Noncontrolling interest | 0 | 339 | 0 |
| Venezuela currency devaluation | 108 | 0 | 0 |
| Asset write-downs | 739 | 2,131 | 160 |
| Net gain on equity investment transactions | (417) | 0 | 0 |
| Deferred tax provision | (607) | (39) | (836) |
| Accounts receivable allowances | (131) | 92 | 32 |
| Changes in assets and liabilities, net of effects from acquisitions: | |||
| Increase in accounts receivable | (632) | (9) | (915) |
| Increase in inventories | (622) | (1) | (715) |
| Increase in accounts payable and accrued liabilities | 1,821 | 2,768 | 493 |
| Increase in other current and non-current assets | (1,806) | (2,172) | (1,785) |
| Increase/(decrease) in other current and non-current liabilities | 298 | (2,555) | 4,413 |
| Net cash flows from operating activities | 17,414 | 15,396 | 14,298 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Additions to property, plant and equipment | (3,595) | (2,934) | (2,893) |
| Proceeds from the disposal of assets | 458 | 1,509 | 1,342 |
| Acquisitions, net of cash acquired (Note 20) | (835) | (4,486) | (2,797) |
| Purchases of investments | (18,923) | (13,434) | (29,882) |
| Sales of investments | 18,058 | 14,797 | 30,396 |
| Other (primarily intangibles) | (266) | 38 | (778) |
| Net cash used by investing activities | (5,103) | (4,510) | (4,612) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Dividends to shareholders | (7,286) | (6,614) | (6,156) |
| Repurchase of common stock | (3,538) | (12,919) | (2,525) |
| Proceeds from short-term debt | 1,411 | 3,268 | 9,729 |
| Retirement of short-term debt | (1,397) | (6,175) | (11,200) |
| Proceeds from long-term debt | 3,607 | 45 | 4,470 |
| Retirement of long-term debt | (1,593) | (804) | (16) |
| Proceeds from the exercise of stock options/excess tax benefits | 2,649 | 2,720 | 1,246 |
| Other | 56 | (83) | 0 |
| Net cash used by financing activities | (6,091) | (20,562) | (4,452) |
| Effect of exchange rate changes on cash and cash equivalents | (204) | 45 | (47) |
| Increase/(decrease) in cash and cash equivalents | 6,016 | (9,631) | 5,187 |
| Cash and cash equivalents, beginning of year (Note 1) | 14,911 | 24,542 | |
| Cash and cash equivalents, end of year (Note 1) | 20,927 | 14,911 | 24,542 |
| Supplemental schedule of non-cash investing and financing activities | |||
| Interest | 596 | 616 | 576 |
| Interest, net of amount capitalized | 491 | 501 | 492 |
| Income taxes | 3,155 | 2,507 | 2,970 |
| Treasury Stock Issued For Employee Compensation And Stock Option Plans Net Of Cash Proceeds | 743 | 615 | 433 |
| Conversion of debt | 22 | 0 | 1 |
| Acquisitions | |||
| Fair value of assets acquired | 1,028 | 19,025 | 3,025 |
| Fair value of liabilities assumed and non-controlling interests | (193) | (1,204) | (228) |
| Net fair value of acquisitions | 835 | 17,821 | 2,797 |
| Net cash paid for aquisitions | 835 | 4,486 | 2,797 |
| Statement, Business Segments | |||
| Synthes, Inc | |||
| Issuance of common stock associated with the acquisition of Synthes | 0 | 13,335 | 0 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2013 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 29, 2013 10-K (Filed: Feb 21, 2014) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 29, 2013 | Dec 30, 2012 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 20,927 | 14,911 |
| Marketable securities (Notes 1 and 2) | 8,279 | 6,178 |
| Accounts receivable trade, less allowances for doubtful accounts $333 (2012, $466) | 11,713 | 11,309 |
| Inventories (Notes 1 and 3) | 7,878 | 7,495 |
| Deferred taxes on income (Note 8) | 3,607 | 3,139 |
| Prepaid expenses and other receivables | 4,003 | 3,084 |
| Total current assets | 56,407 | 46,116 |
| Property, plant and equipment, net (Notes 1 and 4) | 16,710 | 16,097 |
| Intangible assets, net (Notes 1 and 5) | 27,947 | 28,752 |
| Goodwill (Notes 1 and 5) | 22,798 | 22,424 |
| Deferred taxes on income (Note 8) | 3,872 | 4,541 |
| Other assets | 4,949 | 3,417 |
| Total assets | 132,683 | 121,347 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Loans and notes payable (Note 7) | 4,852 | 4,676 |
| Accounts payable | 6,266 | 5,831 |
| Accrued liabilities | 7,685 | 7,299 |
| Accrued rebates, returns and promotions | 3,308 | 2,969 |
| Accrued compensation and employee related obligations | 2,794 | 2,423 |
| Accrued taxes on income | 770 | 1,064 |
| Total current liabilities | 25,675 | 24,262 |
| Long-term debt (Note 7) | 13,328 | 11,489 |
| Deferred taxes on income (Note 8) | 3,989 | 3,136 |
| Employee related obligations (Notes 9 and 10) | 7,784 | 9,082 |
| Other liabilities | 7,854 | 8,552 |
| Total liabilities | 58,630 | 56,521 |
| Shareholders' equity: | ||
| Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (Note 13) | (2,860) | (5,810) |
| Retained earnings | 89,493 | 85,992 |
| Stockholders' Equity before Treasury Stock | 89,753 | 83,302 |
| Less: common stock held in treasury, at cost (Note 12) (299,215,000 shares and 341,354,000 shares) | 15,700 | 18,476 |
| Total shareholders equity | 74,053 | 64,826 |
| Total liabilities and shareholders equity | 132,683 | 121,347 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |